Is the RBS share price now the biggest bargain on the FTSE 100?

Harvey Jones refuses to give up on Royal Bank of Scotland plc (LON: RBS) and thinks one day it simply has to recover.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you hold shares in CYBG (LSE: CYBG) you will be hurting today, as the Clydesdale & Yorkshire Bank owner is down 14% as it warned markets of a massive PPI hit. It makes Royal Bank of Scotland Group (LSE: RBS) look positively healthy by comparison. 

Cry PPI

CYBG’s PPI nightmare completely overshadowed news of a 13% rise in underlying profit before tax to £331m over the year to September, with the bank making a statutory loss after tax of £145m (down from a profit of £182m in 2017) due to far greater than anticipated legacy PPI costs. 

Total PPI provision during 2018 was £352m plus £44m for other legacy conduct. Management said that weekly complaint volumes have been falling since the end of July but it still increased provisions by a “prudent” £150m to cover complaints before the final time bar in August 2019. This reduced the group’s common equity tier 1 ratio by around 182bps to 10.5%.

Low interest

The £3bn banking group, which recently completed its acquisition of Virgin Money, also reported a 1% rise in net interest income, while customer deposits, loans and mortgages all grew more than 4%. Underlying costs fell 6% to £635m, ahead of guidance.

Its shares have taken a beating to hit their lowest level since April 2016. CYBG now trades at 9.8 times forecast earnings, which could be a buying opportunity for those willing to see through its PPI stresses. However, although it increased its ordinary dividend to 3.1p per share, it still offers a forecast yield of just 0.8%, but is expected to hit 4.1% next year. Today could be an opportunity to go bottom fishing. However, it’s been a turnaround prospect a little too long for my liking.

Down and out

The banking sector has been tough for the big boys as well. FTSE 100 giant RBS was the biggest villain in the banking crisis and has taken longest to restore its reputation (and bottom line), as it continues to struggle to this day.

The £25bn company trades 33% lower than it did five years ago, and it wasn’t considered to be doing very well then. RBS has also been hit hard by the PPI crisis, along with just about everything else, and will be gratefully awaiting next August’s deadline (and dreading the last-minute claims rush).

Income hero

Even the news that RBS is restoring its dividend in August has failed to trigger a turnaround. Yet it is on course to be a top income stock, with a forecast yield of 3.1%, covered 4.1 times, which analysts reckon could hit 5.8% next year. That is a huge jump from zero.

RBS is trading at a tempting valuation of just 7.7 times forecast earnings, but still investors are shying away. Many were unhappy to see it report a 6.4% drop in first half operating profits to £1.83bn, even though this was made to look worse by an £801m charge for litigation and misconduct issues, double the previous year’s £396m.

Chief executive Ross McEwan has made progress but revenue growth looks sluggish-to-non-existent and the UK economy is mired in uncertainty, which hardly helps. Yet I can’t help thinking there’s an opportunity here, for the very long-sighted.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

harveyj has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »